Patient Information Resources

1089 Spadina Road
Toronto, AL M5N 2M7
Ph: 416-483-2654
Fax: 416-483-2654

Child Orthopedics
Spine - Cervical
Spine - Lumbar
Spine - Thoracic

View Web RX

« Back

I was one of the first patients to receive the new Carticel made by a company called Genzyme. I've had a great result. I was wondering how other people came out?

Carticel is a cartilage implant that was first used in clinical trials in 1995. The FDA approved its use for the general public in 1997. Since that time, one major study has been published by the FDA's Center for Biologics Evaluations and Research.

At least 7500 patients have been given Carticel for defects in the knee joint cartilage. There were 294 reported cases of problems such as graft failure, infection, tissue overgrowth, or splitting of the implant into two or more layers. This represents a 3.8 percent rate of adverse events (AE).

All in all most patients had a good result. A 3.8 percent complication rate is fairly low. The AEs reported were typical of knee surgery for this type of knee problem. Carticel will continue to be used and results reported.


« Back

*Disclaimer:*The information contained herein is compiled from a variety of sources. It may not be complete or timely. It does not cover all diseases, physical conditions, ailments or treatments. The information should NOT be used in place of visit with your healthcare provider, nor should you disregard the advice of your health care provider because of any information you read in this topic.

All content provided by eORTHOPOD® is a registered trademark of Mosaic Medical Group, L.L.C.. Content is the sole property of Mosaic Medical Group, LLC and used herein by permission.